Literature DB >> 9916833

Guidelines for the medical surveillance of shift workers.

G Costa1.   

Abstract

Occupational health physicians should evaluate workers' fitness for shift and night work before their assignment, at regular intervals, and in cases of health problems connected with night work. The evaluation should be accompanied by a careful job analysis to ensure that shift schedules are arranged according to ergonomic criteria. This arrangement can reduce health problems and make coping with irregular workhours possible, even for people suffering from contraindicative illnesses. Both health disorders representing absolute or relative contraindication and actual work conditions should be taken into account. Health checks should be aimed at detecting early signs of intolerance, such as sleeping and digestive trouble, drug consumption, accidents, and reproductive function. Their periodicity should be set in relation to specific work conditions, individual characteristics, and social factors known to influence tolerance to shift work. Shift workers should receive clear information on the possible negative effect of shift work, and also counseling for coping with shift and night work.

Entities:  

Mesh:

Year:  1998        PMID: 9916833

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  3 in total

1.  Shift work and health: current problems and preventive actions.

Authors:  Giovanni Costa
Journal:  Saf Health Work       Date:  2010-12-30

2.  A cross-sectional study of shift work, sleep quality and cardiometabolic risk in female hospital employees.

Authors:  P Lajoie; K J Aronson; A Day; J Tranmer
Journal:  BMJ Open       Date:  2015-03-10       Impact factor: 2.692

3.  Main effects of sleep disorders related to shift work-opportunities for preventive programs.

Authors:  Stojan Bajraktarov; Antoni Novotni; Nensi Manusheva; Dance G Nikovska; Elizabet Miceva-Velickovska; Natasha Zdraveska; Valentina C Samardjiska; Kneginja S Richter
Journal:  EPMA J       Date:  2011-10-21       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.